|
|
|
Volumn 2, Issue 7, 2004, Pages 435-437
|
|
SRC as a potential therapeutic target in solid tumor oncology.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
EPIDERMAL GROWTH FACTOR RECEPTOR;
HER1 PROTEIN, HUMAN;
PROTEIN KINASE INHIBITOR;
PROTEIN KINASE P60;
ARTICLE;
BONE TUMOR;
CLINICAL TRIAL;
DRUG ANTAGONISM;
DRUG DELIVERY SYSTEM;
DRUG DESIGN;
DRUG EFFECT;
ENZYMOLOGY;
GENETICS;
HUMAN;
METASTASIS;
NEOPLASM;
ONCOGENE SRC;
OSTEOCLAST;
PATIENT SELECTION;
PHOSPHORYLATION;
PHYSIOLOGY;
PROTEIN PROCESSING;
ANTINEOPLASTIC AGENTS;
BONE NEOPLASMS;
CLINICAL TRIALS;
DRUG DELIVERY SYSTEMS;
DRUG DESIGN;
GENES, SRC;
HUMANS;
NEOPLASMS;
OSTEOCLASTS;
PATIENT SELECTION;
PHOSPHORYLATION;
PROTEIN KINASE INHIBITORS;
PROTEIN PROCESSING, POST-TRANSLATIONAL;
PROTO-ONCOGENE PROTEINS PP60(C-SRC);
RECEPTOR, EPIDERMAL GROWTH FACTOR;
|
|
EID: 34548650851
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|
